We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Aster DM Healthcare Limited operates as a healthcare company in India and internationally. It provides primary, secondary, tertiary, and quaternary healthcare services through 29 hospitals, 120 clinics, 371 retail pharmacies, 114 labs, and patient experience centers under the Aster, Medcare, and Access brands. The company was founded in 1987 and is headquartered in Dubai, the United Arab Emirates.
TODAY'S HIGH
180
TODAY'S LOW
175.05
52 WEEK HIGH
237
52 WEEK LOW
148.4
% of Shares Held by
All Insider
55.64%
% of Shares Held by
Institutions
36.95%
% of Float Held by
Institutions
83.29%
Number of Institutions
Holding Shares
35
MARKET CAP
8923.83 Cr.
ETERPRISE VALUE
13782.88 Cr.
NO. OF SHARES
49.95 Cr.
BOOK VALUE
79.518
DIV. YIELD
None%
DEBT
4907.13 Cr.
GROSS PROFIT
3842.32 Cr.
CASH
386.25 Cr.
REVENUE
10253.28 Cr.
REVENUE/SHARE
206.239
Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|
Investments | 0 | 52.88 Cr. | 69.49 Cr. | -17.47 Cr. |
Change To Liabilities | 0 | 0 | 0 | 0 |
Total cashflows from Investing Activities | 0 | -330.30 Cr. | -667.28 Cr. | -708.91 Cr. |
Net Borrowings | 0 | -943.05 Cr. | -217.38 Cr. | 292.87 Cr. |
Total Cash from Financing Activities | 0 | -1116.13 Cr. | -674.80 Cr. | 134.42 Cr. |
Other Liabilities | 0 | 65.27 Cr. | 297.92 Cr. | 196.77 Cr. |
Total Assets | 0 | 79 Lakhs | 1.04 Cr. | 2.43 Cr. |
Net Income | 0 | 147.74 Cr. | 276.61 Cr. | 333.11 Cr. |
Change in Cash | 0 | 119.90 Cr. | -109.92 Cr. | 32.93 Cr. |
Effect of Exchange Rate | 0 | -2.79 Cr. | 8.91 Cr. | 6.50 Cr. |
Total Cash from Operating Activities | 0 | 1569.12 Cr. | 1223.25 Cr. | 600.92 Cr. |
Depreciation | 0 | 609.38 Cr. | 574.67 Cr. | 301.24 Cr. |
Other Cashflows from Investing Activities | 0 | 3.26 Cr. | 4.75 Cr. | 8.52 Cr. |
Dividends Paid | 0 | 0 | 0 | 0 |
Change to Inventory | 0 | 94.57 Cr. | -148.66 Cr. | -63.38 Cr. |
Change to Account Receivables | 0 | 35.95 Cr. | -326.55 Cr. | -555.50 Cr. |
Other Cashflows from Financing Activities | 0 | -173.87 Cr. | -338.46 Cr. | -160.88 Cr. |
Change to Net Income | 0 | 608.02 Cr. | 542.85 Cr. | 383.45 Cr. |
Capital Expenditures | 0 | -404.26 Cr. | -523.87 Cr. | -567.66 Cr. |
Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|
Research Development | None | None | None | None |
Effect of Accounting Charges | None | None | None | None |
Income Before Tax | 0 | 205.05 Cr. | 330.04 Cr. | 410.25 Cr. |
Minority Interest | 0 | 461.66 Cr. | 446.37 Cr. | 466.06 Cr. |
Net Income | 0 | 447.51 Cr. | 677.10 Cr. | 557.69 Cr. |
Selling General Administrative | 0 | 804.06 Cr. | 882.62 Cr. | 434.24 Cr. |
Gross Profit | 0 | 2906.33 Cr. | 3030.76 Cr. | 2739.51 Cr. |
Ebit | 0 | 447.51 Cr. | 677.10 Cr. | 557.69 Cr. |
Operating Income | 0 | 447.51 Cr. | 677.10 Cr. | 557.69 Cr. |
Other Operating Expenses | 0 | 1037.19 Cr. | 889.96 Cr. | 1441.11 Cr. |
Interest Expense | 0 | -292.09 Cr. | -314 Cr. | -158.98 Cr. |
Extraordinary Items | None | None | None | None |
Non Recurring | None | None | None | None |
Other Items | None | None | None | None |
Income Tax Expense | 0 | 27.22 Cr. | 15.38 Cr. | 42.94 Cr. |
Total Revenue | 0 | 8608.43 Cr. | 8651.88 Cr. | 7962.71 Cr. |
Total Operating Expenses | 0 | 8160.92 Cr. | 7974.78 Cr. | 7405.02 Cr. |
Cost of Revenue | 0 | 5702.10 Cr. | 5621.12 Cr. | 5223.20 Cr. |
Total Other Income Expense Net | 0 | -242.46 Cr. | -347.06 Cr. | -147.44 Cr. |
Discontinued Operations | None | None | None | None |
Net Income from Continuous Ops. | 0 | 177.83 Cr. | 314.66 Cr. | 367.31 Cr. |
Net Income Applicable to Common Shares | 0 | 147.74 Cr. | 276.61 Cr. | 333.11 Cr. |
Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|
Intangible Assets | 0 | 249.98 Cr. | 216.60 Cr. | 126.89 Cr. |
Capital Surplus | 0 | 2200.06 Cr. | 2198.80 Cr. | 2329.84 Cr. |
Total Liabilities | 0 | 7809.34 Cr. | 8719.33 Cr. | 5256.59 Cr. |
Stock Holder Equity | 0 | 3372.46 Cr. | 3272.14 Cr. | 3213.76 Cr. |
Minority Interest | 0 | 461.66 Cr. | 446.37 Cr. | 466.06 Cr. |
Other Liabilities | 0 | 264.90 Cr. | 211.40 Cr. | 226.41 Cr. |
Total Assets | 0 | 11643.46 Cr. | 12437.84 Cr. | 8936.41 Cr. |
Common Stock | 0 | 497.04 Cr. | 496.80 Cr. | 505.23 Cr. |
Retained Earnings | 0 | -92.02 Cr. | -225.73 Cr. | -247.25 Cr. |
Other Liabilities | 0 | 584.01 Cr. | 655.64 Cr. | 623.28 Cr. |
Good Will | 0 | 1052.24 Cr. | 1068.74 Cr. | 839.65 Cr. |
Treasury Stock | 0 | 767.38 Cr. | 802.27 Cr. | 625.94 Cr. |
Other Assets | 0 | 292.93 Cr. | 459.86 Cr. | 455.81 Cr. |
Cash | 0 | 258.09 Cr. | 150.80 Cr. | 227.64 Cr. |
Current Liabilities | 0 | 3195.62 Cr. | 3722.08 Cr. | 2667.59 Cr. |
Long Term Asset Charges | 0 | 23.44 Cr. | 32.52 Cr. | 8.30 Cr. |
Short Long Term Debt | 0 | 394.87 Cr. | 493.02 Cr. | 177.32 Cr. |
Other Stockholder Equity | 0 | 767.38 Cr. | 802.27 Cr. | 644.97 Cr. |
Property Plant Equipment | 0 | 6380.57 Cr. | 6574.22 Cr. | 3872.01 Cr. |
Total Cur. Assets | 0 | 3629.01 Cr. | 4095.67 Cr. | 3616.69 Cr. |
Long Term Investments | 0 | 38.73 Cr. | 22.75 Cr. | 25.36 Cr. |
Net Tangible Assets | 0 | 2070.24 Cr. | 1986.80 Cr. | 2247.22 Cr. |
Short Term Investments | 0 | 23.63 Cr. | 10.72 Cr. | 19.55 Cr. |
Net Receivables | 0 | 2265.06 Cr. | 2706.88 Cr. | 2313.65 Cr. |
Long Term Debt | 0 | 1754.80 Cr. | 1892.24 Cr. | 1853.23 Cr. |
Inventory | 0 | 868.14 Cr. | 999.74 Cr. | 758.42 Cr. |
Accounts Payable | 0 | 2027.34 Cr. | 2110.35 Cr. | 1014.07 Cr. |